- Home
- SGRP vs IGC Comparison
SGRP vs IGC Comparison
Compare SGRP & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- IGC
- Stock Information
- Founded
- SGRP 1967
- IGC 2005
- Country
- SGRP United States
- IGC United States
- Employees
- SGRP N/A
- IGC N/A
- Industry
- SGRP Business Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- SGRP Consumer Discretionary
- IGC Health Care
- Exchange
- SGRP Nasdaq
- IGC Nasdaq
- Market Cap
- SGRP 31.7M
- IGC 19.1M
- IPO Year
- SGRP 1996
- IGC N/A
- Fundamental
- Price
- SGRP $1.30
- IGC $0.29
- Analyst Decision
- SGRP
- IGC Strong Buy
- Analyst Count
- SGRP 0
- IGC 2
- Target Price
- SGRP N/A
- IGC $3.88
- AVG Volume (30 Days)
- SGRP 81.2K
- IGC 403.0K
- Earning Date
- SGRP 05-14-2025
- IGC 02-18-2025
- Dividend Yield
- SGRP N/A
- IGC N/A
- EPS Growth
- SGRP N/A
- IGC N/A
- EPS
- SGRP 0.50
- IGC N/A
- Revenue
- SGRP $228,869,000.00
- IGC $1,236,000.00
- Revenue This Year
- SGRP N/A
- IGC N/A
- Revenue Next Year
- SGRP N/A
- IGC $18.34
- P/E Ratio
- SGRP $2.67
- IGC N/A
- Revenue Growth
- SGRP N/A
- IGC 1.65
- 52 Week Low
- SGRP $1.23
- IGC $0.26
- 52 Week High
- SGRP $3.12
- IGC $0.91
- Technical
- Relative Strength Index (RSI)
- SGRP 27.38
- IGC 39.34
- Support Level
- SGRP $1.36
- IGC $0.28
- Resistance Level
- SGRP $1.60
- IGC $0.32
- Average True Range (ATR)
- SGRP 0.08
- IGC 0.02
- MACD
- SGRP 0.02
- IGC -0.00
- Stochastic Oscillator
- SGRP 22.68
- IGC 4.00
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.